Literature DB >> 11403530

Practice parameters for the treatment of narcolepsy: an update for 2000.

M Littner1, S F Johnson, W V McCall, W M Anderson, D Davila, S K Hartse, C A Kushida, M S Wise, M Hirshkowitz, B T Woodson.   

Abstract

Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with other sleep disorders, which have different treatments, and to avoid unnecessary complications of drug treatment. Treatment objectives should be tailored to individual circumstances. Modafinil, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, selegiline, pemoline, tricyclic antidepressants, and fluoxetine are effective treatments for narcolepsy, but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness, but naps seldom suffice as primary therapy. Regular follow up of patients with narcolepsy is necessary to educate patients and their families, monitor for complications of therapy and emergent of other sleep disorders, and help the patient adapt to the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11403530

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  21 in total

Review 1.  Narcolepsy and excessive daytime sleepiness.

Authors:  Adam Zeman; Tom Britton; Neil Douglas; Andrew Hansen; Jane Hicks; Robin Howard; Andrew Meredith; Ian Smith; Gregory Stores; Sue Wilson; Zenobia Zaiwalla
Journal:  BMJ       Date:  2004-09-25

2.  Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.

Authors:  W G Ondo; R Fayle; F Atassi; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

4.  Conception, pregnancy, delivery, and breastfeeding in a narcoleptic patient with cataplexy.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

5.  Diagnosis and management of central hypersomnias.

Authors:  Karel Sonka; Marek Susta
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

6.  Recognition and management of excessive sleepiness in the primary care setting.

Authors:  Jonathan R L Schwartz; Thomas Roth; Max Hirshkowitz; Kenneth P Wright
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

7.  Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.

Authors:  Charles A Czeisler; James K Walsh; Keith A Wesnes; Sanjay Arora; Thomas Roth
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 8.  Bipolar disorder: candidate drug targets.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Mt Sinai J Med       Date:  2008 May-Jun

9.  Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test.

Authors:  Angela M Anniss; Alan Young; Denise M O'Driscoll
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 10.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.